SynBioBeta

Subscribers Only

Access Now

ResVita Bio receives Rare Pediatric Disease Designation for RVB-001 as a Treatment for Netherton Syndrome

Subscribers Only

Slingshot Biosciences, Inc. Partners With Cambridge Bioscience to Distribute Synthetic Cells Throughout United Kingdom and Ireland

Subscribers Only

CHAIN Biotech and the University of Oxford collaborate to tackle oral vaccine inequality

Subscribers Only

Codagenix Completes Dosing in Phase 1 Trial of Universal Influenza Vaccine

Subscribers Only

GenScript Launches GMP Single-Strand and Double-Strand DNA Service for Supporting Gene and Cell Therapy Development

Subscribers Only

BigHat Biosciences Appoints Rob Chess, Serial Entrepreneur, to its Board of Directors

Subscribers Only

SNIPR BIOME Initiates First-in-Human Clinical Trial with SNIPR001

Subscribers Only

Twist Bioscience Signs Antibody Discovery Collaboration with MediSix Therapeutics to Develop T-cell Therapies

Subscribers Only

Pangea Biomed Launches with World’s Most Advanced Multi-Cancer Response Predictor, Increasing Patient Benefits from Precision Oncology by 5x

Subscribers Only

Demetrix and Evonik Sign Supply Agreement for Cannabinoids

Subscribers Only

Evozyne Announces Multi-Target Research Collaboration and License Agreement with Takeda to Develop Next-Generation Gene Therapies

Subscribers Only

LifeMine Therapeutics Announces $175 Million Series C Financing

Subscribers Only

RootPath Launches, Elevating Throughput of Gene Function Interrogation by Orders of Magnitude

Subscribers Only

Twist Bioscience Launches Synthetic RNA Positive Controls for SARS-CoV-2 Encapsulated in Imagene’s Stainless Steel Capsules

Subscribers Only

Demetrix Initiates 2022 Commercial Manufacturing Campaign

Subscribers Only

A-Alpha Bio and Lawrence Livermore National Laboratory collaborate to accelerate therapeutic antibody discovery against emerging COVID-19 variants

Subscribers Only

Lilly to Supply up to 600,000 Doses of AbCellera-Discovered Antibody, Bebtelovimab, to the U.S. Government in Ongoing Effort to Provide COVID-19 Treatments

Subscribers Only

Intellia Therapeutics Announces Acquisition of Rewrite Therapeutics

Subscribers Only

Twist Bioscience Signs Collaboration with Artisan Bio to Engineer Next Generation Cell Therapeutics

Subscribers Only

Prokarium Expands R&D Capabilities with London Biofoundry to Deepen Microbial Immunotherapy Pipeline

The Future of Epidemic Prevention Lies in Wastewater Analysis

ResVita Bio receives Rare Pediatric Disease Designation for RVB-001 as a Treatment for Netherton Syndrome

Slingshot Biosciences, Inc. Partners With Cambridge Bioscience to Distribute Synthetic Cells Throughout United Kingdom and Ireland

CHAIN Biotech and the University of Oxford collaborate to tackle oral vaccine inequality

Codagenix Completes Dosing in Phase 1 Trial of Universal Influenza Vaccine

GenScript Launches GMP Single-Strand and Double-Strand DNA Service for Supporting Gene and Cell Therapy Development

BigHat Biosciences Appoints Rob Chess, Serial Entrepreneur, to its Board of Directors

SNIPR BIOME Initiates First-in-Human Clinical Trial with SNIPR001

Twist Bioscience Signs Antibody Discovery Collaboration with MediSix Therapeutics to Develop T-cell Therapies

Pangea Biomed Launches with World’s Most Advanced Multi-Cancer Response Predictor, Increasing Patient Benefits from Precision Oncology by 5x

Demetrix and Evonik Sign Supply Agreement for Cannabinoids

Evozyne Announces Multi-Target Research Collaboration and License Agreement with Takeda to Develop Next-Generation Gene Therapies

LifeMine Therapeutics Announces $175 Million Series C Financing

RootPath Launches, Elevating Throughput of Gene Function Interrogation by Orders of Magnitude

Twist Bioscience Launches Synthetic RNA Positive Controls for SARS-CoV-2 Encapsulated in Imagene’s Stainless Steel Capsules

Demetrix Initiates 2022 Commercial Manufacturing Campaign

A-Alpha Bio and Lawrence Livermore National Laboratory collaborate to accelerate therapeutic antibody discovery against emerging COVID-19 variants

Lilly to Supply up to 600,000 Doses of AbCellera-Discovered Antibody, Bebtelovimab, to the U.S. Government in Ongoing Effort to Provide COVID-19 Treatments

Intellia Therapeutics Announces Acquisition of Rewrite Therapeutics

Twist Bioscience Signs Collaboration with Artisan Bio to Engineer Next Generation Cell Therapeutics

Prokarium Expands R&D Capabilities with London Biofoundry to Deepen Microbial Immunotherapy Pipeline